Lightcalls.com
 

A recent study in the June 14 2003 ...

A recent study in the June 14 2003 issue of The Lancet presents the best evidence yet that appendixs of vitamin E or beta-carotene--two of the antioxidant vitamins--don't screen the heart, as once believed.

The Cleveland Clinic Foundation (CCF) analyzed 15 major studies of nearly 220000 the community before coming to these conclusions. This is considered a large-scale subject of attention which looked at high and soft doses, at both sexes of all ages and at all causes of death--not just heart disease. Neither vitamin E nor beta-carotene reduc mortality; in fact, beta-carotene was build to increase cardiac risk for smokers

It may be that in order to be effective, these antioxidant vitamins require certain unites found in the whole rationss that furnish them.

In the various studies analyzed according to the CCF, the doses for vitamin E ranged from 50 to 800 International Units (IUs) daily. Beta-carotene doses ranged from 15 to S0 mg daily.



The overall death rate--whether from heart disease or any other cause--was the same for all form into groupss whether vitamin E was taken or not.

For those taking beta-carotene, however, the outcomes were slightly worse. There was a small unless significant increase in deaths--from all causes--in the disposes taking beta-carotene.

John Hathcock, PhD the vice president of the Council for Responsible Nutrition (CRN)--a trade association representing dietary counterpart suppliers and manufacturers--argues that this does not control out a possible "primary benefit."

In other words, there may be no benefit from vitamin E and beta-carotene postscripts for people already showing detectable cardiac symptoms--but these antioxidants could still provide protection if taken before atherosclerosis lay opens Hathcock also stresses that the data indicates beta-carotene no other than raises the risk of death for those who smoke

Antioxidant vitamins A and E may not provide cardiac protection still are linked with cancer risk reduction. Also, earlier studies indicated that folic acid and vitamins [Bsub12] and [Bsub6] help heart disease patients.

COPYRIGHT 2003 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2003 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.